+39 02 610346.1 - info@newron.com

Latest press releases

  • 22Sep
    Newron re-submits US NDA for Xadago® (safinamide)

     

  • 15Sep
    Newron reports half-year 2016 results

     

  • 1Sep
    Zambon Launches Xadago® (Safinamide) In Norway For Patients With Mid- To Late-Stage Parkinson’s Disease

     

  • 26Jul
    Newron to re-submit US NDA for Xadago® (safinamide) - no additional evaluation of abuse liability or dependence/withdrawal effects required

     

  • 21Jul
    Newron Pharmaceuticals Announces Initiation of the STARS Study in the United States

         video testimonial

  • 6Jul
    Zambon Launches Xadago® (Safinamide) In The Netherlands For Patients With Mid- To Late-Stage Parkinson’s Disease

     

View All

Newron share price

Events

  • 29Nov
    28th Annual Piper Jaffray Healthcare Conference

    November 29 and 30, 2016 - The Lotte New York Palace, New York - USA

  • 22Nov
    German Equity Forum (Deutsches Eigenkapitalforum)

    November 21-23, 2016 - Frankfurt-am-Main - Germany

  • 23Aug
    Bellevue Healthcare Day

    August 23, 2016 - Marriott Hotel, Zurich, Switzerland

View Event Calendar